{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:30Z","timestamp":1792601490365,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":638,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Aging Research & Lifestyle"],"published-print":{"date-parts":[[2023]]},"DOI":"10.14283\/jarlife.2023.8","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T11:11:56Z","timestamp":1687345916000},"page":"35-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Comparative Effectiveness of Monotherapy and Combination Therapies: Impact of Angiotensin Receptor Blockers on the Onset of Alzheimer's Disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Kazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.14283\/jarlife.2023.8_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"\u201cLecanemab in Early Alzheimer's Disease.\u201d","volume":"388","author":"van Dyck","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"10.14283\/jarlife.2023.8_bib2","article-title":"D. For the Alzheimer's and G. Related Disorders Therapeutics Work. \u201cLecanemab: Appropriate Use Recommendations.\u201d","author":"Cummings","year":"2023","journal-title":"The Journal of Prevention of Alzheimer's Disease"},{"issue":"12","key":"10.14283\/jarlife.2023.8_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41582-020-0397-4","article-title":"\u201cDrug repositioning and repurposing for Alzheimer disease.\u201d","volume":"16","author":"Ballard","year":"2020","journal-title":"Nature Reviews Neurology"},{"key":"10.14283\/jarlife.2023.8_bib4","doi-asserted-by":"crossref","first-page":"100012","DOI":"10.1016\/j.crphar.2020.100012","article-title":"\u201cPerspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal.\u201d","volume":"2","author":"Bhat","year":"2021","journal-title":"Current Research in Pharmacology and Drug Discovery"},{"issue":"6","key":"10.14283\/jarlife.2023.8_bib5","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/med.21709","article-title":"\u201cHarnessing endophenotypes and network medicine for Alzheimer's drug repurposing.\u201d","volume":"40","author":"Fang","year":"2020","journal-title":"Medicinal research reviews"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0192-4","article-title":"\u201cComorbidity and dementia: a scoping review of the literature.\u201d","volume":"12","author":"Bunn","year":"2014","journal-title":"BMC medicine"},{"issue":"6","key":"10.14283\/jarlife.2023.8_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.clinthera.2021.05.006","article-title":"\u201cModifiable risk factors in Alzheimer disease and related dementias: a review.\u201d","volume":"43","author":"Litke","year":"2021","journal-title":"Clinical Therapeutics"},{"issue":"340","key":"10.14283\/jarlife.2023.8_bib8","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"\u201cUse of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.\u201d","volume":"340","author":"Li","year":"2010","journal-title":"Bmj"},{"issue":"4","key":"10.14283\/jarlife.2023.8_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/HJH.0000000000000086","article-title":"\u201cAngiotension receptor blockers reduce the risk of dementia.\u201d","volume":"32","author":"Chiu","year":"2014","journal-title":"Journal of hypertension"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib10","first-page":"73","article-title":"\u201cAngiotensin-Receptor Blockers and the Risk of Alzheimer\u00b4 s Disease: A Meta-analysis.\u201d","volume":"16","author":"Oscanoa","year":"2021","journal-title":"Current Reviews in Clinical and Experimental Pharmacology Formerly Current Clinical Pharmacology"},{"issue":"4","key":"10.14283\/jarlife.2023.8_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/1567205014666171016101816","article-title":"\u201cPharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer's disease dementia.\u201d","volume":"15","author":"de Oliveira","year":"2018","journal-title":"Current Alzheimer Research"},{"issue":"20","key":"10.14283\/jarlife.2023.8_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-5-20","article-title":"\u201cSimvastatin is associated with a reduced incidence of dementia and Parkinson's disease.\u201d","volume":"5","author":"Wolozin","year":"2007","journal-title":"BMC Med"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-94803-3","article-title":"\u201cAssociation between statin use and Alzheimer's disease with dose response relationship.\u201d","volume":"11","author":"Jeong","year":"2021","journal-title":"Scientific reports"},{"issue":"11","key":"10.14283\/jarlife.2023.8_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/JGP.0b013e318181276a","article-title":"\u201cEffects of cardiovascular medications on rate of functional decline in Alzheimer disease.\u201d","volume":"16","author":"Rosenberg","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.14283\/jarlife.2023.8_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","article-title":"\u201cMetformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.\u201d","volume":"101","author":"Li","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.14283\/jarlife.2023.8_bib16","doi-asserted-by":"crossref","first-page":"e0229541","DOI":"10.1371\/journal.pone.0229541","article-title":"\u201cAssociation of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.\u201d","volume":"15","author":"Barthold","year":"2020","journal-title":"PloS one"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13195-020-00589-3","article-title":"\u201cBeneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer's disease after traumatic brain injury.\u201d","volume":"12","author":"Li","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.14283\/jarlife.2023.8_bib18","doi-asserted-by":"crossref","first-page":"e0248652","DOI":"10.1371\/journal.pone.0248652","article-title":"\u201cThe association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.\u201d","volume":"16","author":"Li","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.14283\/jarlife.2023.8_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/alz.12665","article-title":"\u201cClinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment.\u201d","volume":"18","author":"Wang","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.14283\/jarlife.2023.8_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCRESAHA.118.313294","article-title":"\u201cTwo-drug combinations as first-step antihypertensive treatment.\u201d","volume":"124","author":"Mancia","year":"2019","journal-title":"Circulation research"},{"issue":"8","key":"10.14283\/jarlife.2023.8_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.0000139857.85424.45","article-title":"\u201cShould angiotensin II receptor blockers and statins be combined?\u201d","volume":"110","author":"Nickenig","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.14283\/jarlife.2023.8_bib22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"\u201cDrug combination therapy increases successful drug repositioning.\u201d","volume":"21","author":"Sun","year":"2016","journal-title":"Drug discovery today"},{"issue":"4","key":"10.14283\/jarlife.2023.8_bib23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"\u201cAssessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.\u201d","volume":"43","author":"Quan","year":"2008","journal-title":"Health services research"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib24","first-page":"24","article-title":"\u201cACE inhibitors and ARBs: One or the other\u2014not both\u2014for high-risk patients.\u201d","volume":"58","author":"Misra","year":"2009","journal-title":"The Journal of family practice"},{"issue":"19","key":"10.14283\/jarlife.2023.8_bib25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/01.wnl.0000334278.11022.42","article-title":"\u201cSurvival in Alzheimer disease: a multiethnic, population-based study of incident cases.\u201d","volume":"71","author":"Helzner","year":"2008","journal-title":"Neurology"},{"key":"10.14283\/jarlife.2023.8_bib26","first-page":"1","article-title":"\u201cPsychosocial risk factors and Alzheimer's disease: the associative effect of depression, sleep disturbance, and anxiety.\u201d","volume":"27","author":"Burke","year":"2017","journal-title":"Aging Ment Health"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/biomet\/54.1-2.167","article-title":"(1967). \u201cEstimation of the probability of an event as a function of several independent variables.\u201d","volume":"54","author":"Walker","year":"1967","journal-title":"Biometrika"},{"key":"10.14283\/jarlife.2023.8_bib28","first-page":"187","article-title":"\u201cRegression models and life tables.\u201d","volume":"34","author":"Cox","year":"1972","journal-title":"Breakthroughs in Statistics"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib29","article-title":"\u201cOverlapping confidence intervals and statistical significance.\u201d","volume":"73","author":"Knezevic","year":"2008","journal-title":"StatNews: Cornell University Statistical Consulting Unit"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/pm\/pnw096","article-title":"\u201cUsing random forest models to identify correlates of a diabetic peripheral neuropathy diagnosis from electronic health record data.\u201d","volume":"18","author":"DuBrava","year":"2017","journal-title":"Pain Medicine"},{"issue":"1","key":"10.14283\/jarlife.2023.8_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-14632-w","article-title":"\u201cUsing random forest to identify longitudinal predictors of health in a 30-year cohort study.\u201d","volume":"12","author":"Loef","year":"2022","journal-title":"Scientific Reports"},{"key":"10.14283\/jarlife.2023.8_bib32","doi-asserted-by":"crossref","first-page":"157312","DOI":"10.1016\/j.scitotenv.2022.157312","article-title":"\u201cEnvironmental variable importance for under-five mortality in Malaysia: a random forest approach.\u201d","volume":"845","author":"Phung","year":"2022","journal-title":"Science of the Total Environment"},{"issue":"10","key":"10.14283\/jarlife.2023.8_bib33","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/bioinformatics\/btq134","article-title":"\u201cPermutation importance: a corrected feature importance measure.\u201d","volume":"26","author":"Altmann","year":"2010","journal-title":"Bioinformatics"},{"issue":"9","key":"10.14283\/jarlife.2023.8_bib34","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s11269-017-1660-3","article-title":"\u201cApplication of support vector machine, random forest, and genetic algorithm optimized random forest models in groundwater potential mapping.\u201d","volume":"31","author":"Naghibi","year":"2017","journal-title":"Water Resources Management"},{"issue":"9","key":"10.14283\/jarlife.2023.8_bib35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","article-title":"\u201cWhitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance.\u201d","volume":"16","author":"Stern","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.14283\/jarlife.2023.8_bib36","first-page":"1279","article-title":"\u201cManaging hypertension using combination therapy.\u201d","volume":"77","author":"Frank","year":"2008","journal-title":"American family physician"},{"issue":"6","key":"10.14283\/jarlife.2023.8_bib37","first-page":"341","article-title":"\u201cManaging hypertension using combination therapy.\u201d","volume":"101","author":"Smith","year":"2020","journal-title":"American family physician"},{"issue":"12","key":"10.14283\/jarlife.2023.8_bib38","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","article-title":"\u201cImpact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series.\u201d","volume":"69","author":"Hajjar","year":"2012","journal-title":"Archives of neurology"},{"key":"10.14283\/jarlife.2023.8_bib40","unstructured":"Amorha, K. C., M. O. Akinleye and O. O. Oyetunde, 2013. \u201cIn Vitro Drug Interactions Study of Lisinopril with Metformin.\u201d"},{"key":"10.14283\/jarlife.2023.8_bib41","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/01.hjh.0000745964.49172.d3","article-title":"\u201cThe effect of metformin administration on blood pressure variability in hypertensive subjects with prediabetes receiving lisinopril\u201d","volume":"39","author":"Hakim","year":"2021","journal-title":"Journal of Hypertension"},{"key":"10.14283\/jarlife.2023.8_bib42","first-page":"1","article-title":"\u201cThe combination of beta-blockers and ACE inhibitors across the spectrum of cardiovascular diseases.\u201d","author":"Strauss","year":"2021","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"12","key":"10.14283\/jarlife.2023.8_bib43","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1592\/phco.23.15.1663.31953","article-title":"\u201cCognitive impairment associated with atorvastatin and simvastatin.\u201d","volume":"23","author":"King","year":"2003","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"issue":"7","key":"10.14283\/jarlife.2023.8_bib44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.23.7.871.32720","article-title":"\u201cStatin-associated memory loss: analysis of 60 case reports and review of the literature.\u201d","volume":"23","author":"Wagstaff","year":"2003","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"issue":"7","key":"10.14283\/jarlife.2023.8_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1592\/phco.29.7.800","article-title":"\u201cStatin-associated adverse cognitive effects: Survey results from 171 patients.\u201d","volume":"29","author":"Evans","year":"2009","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"issue":"10","key":"10.14283\/jarlife.2023.8_bib46","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-159-10-201311190-00007","article-title":"\u201cStatins and cognitive function: a systematic review.\u201d","volume":"159","author":"Richardson","year":"2013","journal-title":"Annals of internal medicine"},{"issue":"3","key":"10.14283\/jarlife.2023.8_bib47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11606-014-3115-3","article-title":"\u201cDo statins impair cognition? A systematic review and meta-analysis of randomized controlled trials.\u201d","volume":"30","author":"Ott","year":"2015","journal-title":"Journal of general internal medicine"},{"issue":"Supplement 2","key":"10.14283\/jarlife.2023.8_bib48","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.2337\/dcS15-3022","article-title":"\u201cRemembering statins: do statins have adverse cognitive effects?\u201d","volume":"39","author":"Bitzur","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.14283\/jarlife.2023.8_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tcm.2016.03.009","article-title":"\u201cDoes statin use cause memory decline in the elderly?\u201d","volume":"26","author":"Samaras","year":"2016","journal-title":"Trends in cardiovascular medicine"},{"issue":"10","key":"10.14283\/jarlife.2023.8_bib50","doi-asserted-by":"crossref","first-page":"14391443","DOI":"10.1001\/archneur.57.10.1439","article-title":"\u201cDecreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.\u201d","volume":"57","author":"Wolozin","year":"2000","journal-title":"Archives of neurology"},{"issue":"11","key":"10.14283\/jarlife.2023.8_bib51","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.3390\/ijms151120607","article-title":"\u201cMolecular mechanisms underlying the effects of statins in the central nervous system.\u201d","volume":"15","author":"McFarland","year":"2014","journal-title":"International journal of molecular sciences"},{"key":"10.14283\/jarlife.2023.8_bib52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00005650-200208000-00007","article-title":"\u201cValidity of information on comorbidity derived from ICD-9-CCM administrative data.\u201d","author":"Quan","year":"2002","journal-title":"Medical care"},{"issue":"9","key":"10.14283\/jarlife.2023.8_bib53","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0895-4356(02)00452-3","article-title":"\u201cThe accuracy of medicare claims data in identifying Alzheimer's disease.\u201d","volume":"55","author":"Taylor","year":"2002","journal-title":"Journal of clinical epidemiology"},{"issue":"10","key":"10.14283\/jarlife.2023.8_bib54","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1212\/WNL.0b013e3182684707","article-title":"\u201cRecommendations for optimal ICD codes to study neurologic conditions: a systematic review.\u201d","volume":"79","author":"Germaine-Smith","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.14283\/jarlife.2023.8_bib55","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1532-5415.2012.03933.x","article-title":"\u201cUnderuse of diagnostic codes for specific dementias in the Veterans Affairs New England healthcare system.\u201d","volume":"60","author":"Butler","year":"2012","journal-title":"Journal of the American Geriatrics Society"},{"issue":"4","key":"10.14283\/jarlife.2023.8_bib56","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"\u201cAssessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.\u201d","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv Res"},{"issue":"4","key":"10.14283\/jarlife.2023.8_bib57","doi-asserted-by":"crossref","first-page":"c407","DOI":"10.1159\/000324164","article-title":"\u201cCan ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients?\u201d","volume":"118","author":"Onuigbo","year":"2011","journal-title":"Nephron Clinical Practice"}],"updated-by":[{"DOI":"10.1016\/j.jarlif.2025.100029","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"container-title":["The Journal of Aging Research & Lifestyle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2534773X24000351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2534773X24000351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:05:54Z","timestamp":1736503554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2534773X24000351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":56,"alternative-id":["S2534773X24000351"],"URL":"https:\/\/doi.org\/10.14283\/jarlife.2023.8","relation":{},"ISSN":["2534-773X"],"issn-type":[{"value":"2534-773X","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Comparative Effectiveness of Monotherapy and Combination Therapies: Impact of Angiotensin Receptor Blockers on the Onset of Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Aging Research & Lifestyle","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jarlife.2023.8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}